Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-10-28

Clinical Trial Update: Development of TcB Nomogram to Identify Neonatal Hyperbilirubinemia in Term and Late-preterm Infants

View source ↗

Summary

The study reports the development of a transcutaneous bilirubin (TcB) nomogram to identify neonatal hyperbilirubinemia in term and late-preterm infants.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Nanjing Medical University | Conditions: Hyperbilirubinemia, Neonatal | Status: COMPLETED